allelebiotech.comAllele Biotech – cGMP iPSCs and Cell Therapy CDMO

Technologies Overview mRNA Reprogramming Licensing Technology Video Hub GMP iPSCs cGMP iPSCs Overview Off-the-Shelf Custom Development Partnership for Autologous Cell Therapy CDMO CDMO Overview cGMP iPSC Manufacturing cGMP iPSC Quality Control cGMP Consulting cGMP Banking Genome Editing CRISPR Genome Editing GMP Genome Editing Gene Editing in iPSCs NewsAllele Biotech cGMP iPSCs and Cell Therapy CDMO Home Technologies Overview mRNA Reprogramming Licensing Technology Video Hub GMP iPSCs cGMP iPSCs Overview Off-the-Shelf Custom Development Partnership for Autologous Cell Therapy CDMO CDMO Overview cGMP iPSC Manufacturing cGMP iPSC Quality Control cGMP Consulting cGMP Banking Genome Editing CRISPR Genome Editing GMP Genome Editing Gene Editing in iPSCs News Home Technologies Overview mRNA Reprogramming Licensing Technology Video Hub GMP iPSCs cGMP iPSCs Overview Off-the-Shelf Custom Development Partnership for Autologous Cell Therapy CDMO CDMO Overview cGMP iPSC Manufacturing cGMP iPSC Quality Control cGMP Consulting cGMP Banking Genome Editing CRISPR Genome Editing GMP Genome Editing Gene Editing in iPSCs News We are Allele, the first dedicated provider of cGMP iPSCs and cell therapy CDMO (development and manufacturing). The only all-in-one provider of clinical grade iPSCs, allied technologies, and CDMO services to accelerate life-saving immuno-oncology and regenerative medicine cell therapy programs. Download our iPSC Buyer’s Guide Technology Video Hub Allele is the one-stop solution for iPSC development Over a decade of experience serving personalized iPSC approaches to clients from start-ups to biopharma companies. We produce the best-in-class commercial-ready iPSCs, providing a clean slate for cell therapy development. iPSCs are consistent, scalable, and devoid of ethical issues ​​Master iPSC lines provide unmatched consistency and are easily scaled-up or frozen down, saving time and money with unparalleled efficiency. Commercial-ready off-the-shelf iPSC lines considerably reduce your development time and make your cell therapies dramatically more cost-effective per dose. Allele is the first cGMP-grade iPSC provider in the US Robust technology: Using a proprietary patented mRNA system, we generate iPSCs that are footprint-free, feeder-free, and xeno-free-—with no risk of genomic integration and no vector cleanup phase. Start with the endpoint in mind: Our iPSCs meet strict regulatory standards, enabling you to seamlessly transition from scientific development to commercial deployment. cGMP from the get-go: From donor recruitment through differentiation, we are your iPSC experts. Explore our capabilities infographic. Explore our capabailities Infographic. Unlock the Potential of iPSCs in Cell Therapy Download our buyer’s guide on donor cell sourcing to learn how to find the best fit for your needs. Download our iPSC Buyer’s Guide Unsure where to get started? Start here. Sourcing donor cells for cell therapy can be complex and challenging. There are so many factors to consider that it can be overwhelming. Contact us so we can find the best fit for your needs. Contact Us Email info@allelebiotech.com Address 6404 Nancy Ridge Dr San Diego, CA 92121 Find us on: Linkedin page opens in new window Quick Links iPSC Buyer’s Guide Patents Reagents Nanoantibodies COVID-19 ©2024 by Allele Biotechnology and Pharmaceuticals...